Quick Answer
Embecta Corp. reported Research And Development Expense of $37.30 million for the year ending 2025.
- Embecta Corp. showed a decrease of -52.7% in Research And Development Expense from 2024 to 2025.
- This data is from Embecta Corp.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2020: $14.00 million | Q1 2021: $14.10 million | Q2 2021: $15.70 million | Q4 2021: $16.70 million | Q1 2022: $18.00 million | Q2 2022: $14.30 million | Q4 2022: $16.90 million | Q1 2023: $22.10 million | Q2 2023: $22.60 million | Q4 2023: $20.20 million | Q1 2024: $18.40 million | Q2 2024: $20.40 million | Q4 2024: $20.30 million | Q1 2025: $8.00 million | Q2 2025: $4.40 million | Q4 2025: $4.60 million.
- Over the full 6 years of available data (2020 to 2025), Embecta Corp.'s Research And Development Expense has declined by 39.3%.
- Historical annual values: Fiscal year 2025: $37.30 million | Fiscal year 2024: $78.80 million | Fiscal year 2023: $85.20 million | Fiscal year 2022: $66.90 million | Fiscal year 2021: $63.30 million | Fiscal year 2020: $61.40 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: